Pfizer in Battle for Britain’s AstraZeneca
Pfizer, the U.S. big pharma drugmaker is trying to secure its next move with its $100 billion fight for Britain's…
Pfizer
Pfizer and General Counsel Amy Schulman Split
It was announced via a press release from Pfizer Inc. that general counsel Amy Schulman will be leaving the company.…
Pristiq Lawsuit Ends with Pfizer Settling for $67.5 Million
On Friday, Pfizer Inc agreed to settle the class-action lawsuit brought by former Wyeth Inc shareholders. The lawsuit had alleged alleged that Wyeth…
Wal-Mart in Compliance with Foreign Corrupt Practices Act?
The best defense is a good offense? That's what one may wonder after Wal-Mart Stores Inc. announced it is launching…
Merck Pays $950 Million in Vioxx Settlement, Settles Criminal and Civil Charges
Pharmaceutical giant Merck will pay $950 million, and has pleaded guilty to a criminal charge regarding the marketing and sales…
Gibson, Dunn & Crutcher Adds Four Partners to NY Office
Four partners, formerly with Orrick, Herrington & Sutcliffe LLP, have joined the New York office of Gibson, Dunn & Crutcher…
Japan Stops Using Pfizer and Sanofi Vaccines after Four Deaths Occur
The use of some pediatric vaccines manufactured by Pfizer Inc. and Sanofi-Aventis SA was suspended by Japan’s health ministry after…
Phillips & Cohen Selected for National Law Journal’s “Hot List” for Whistleblower Work
Phillips & Cohen LLP has been selected for the National Law Journal's "Hot List" of the Top 12 plaintiffs' law…
Loucks Has New Home
Michael K. Loucks, who spent over 20 years as a U.S. attorney in Massachusetts, has joined law firm Skadden, Arps, Slate, Meagher &…
Class Action Filed Against Pfizer by Brualdi
Per Globe Newswire, the Brualdi Law Firm has filed a class action suit against Pfizer in the United States District…
Former Pfizer Assistant General Counsel Joins DLA Piper
Former Pfizer Assistant General Counsel Carlton Wessel joins DLA Piper’s Washington office as a partner today. Wessel was previously a…
Federal Appeals Court Brings Back Fraud Suit Against Pfizer
A federal appeals court rejuvenated a securities fraud suit against Pfizer. Investors claim the company was hiding the truth about…